Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

MT1G Regulates c-MYC/P53 Signal to Inhibit Proliferation, Invasion and Migration and Promote Apoptosis in Colon Cancer Cells

Author(s): Jie Li, Qiaozhen Hu, Zhongyan Li, Kaiyu Feng and Kangbao Li*

Volume 24, Issue 3, 2024

Published on: 09 May, 2023

Page: [379 - 388] Pages: 10

DOI: 10.2174/1566524023666230329085557

Price: $65

Abstract

Introduction: Colon cancer is a common and malignant cancer featuring high morbidity and poor prognosis.

Aims: This study was performed to explore the regulatory role of MT1G in colon cancer as well as its unconcealed molecular mechanism.

Methods: The expressions of MT1G, c-MYC, and p53 were assessed with the application of RT-qPCR and western blot. The impacts of MT1G overexpression on the proliferative ability of HCT116 and LoVo cells were measured by CCK-8 and BrdU incorporation assays. Additionally, transwell wound healing, and flow cytometry assays were employed to evaluate the invasive and migrative capacities as well as the apoptosis level of HCT116 and LoVo cells. Moreover, the activity of the P53 promoter region was assessed with the help of a luciferase reporter assay.

Results: It was found that the expressions of MT1G at both mRNA and protein levels were greatly decreased in human colon cancer cell lines, particularly in HCT116 and LoVo cell lines. After transfection, it was discovered that the MT1G overexpression suppressed the proliferation, migration and invasion but promoted the apoptosis of HCT116 and LoVo cells, which were then partially reversed after overexpressing c-MYC. Additionally, MT1G overexpression reduced c-MYC expression but enhanced the p53 expression, revealing that the MT1G overexpression could regulate c-MYC/P53 signal. Elsewhere, it was also shown that c-MYC overexpression suppressed the regulatory effects of MT1G on P53.

Conclusion: To conclude, MT1G was verified to regulate c-MYC/P53 signal to repress the proliferation, migration and invasion but promote the apoptosis of colon cancer cells, which might offer a novel targeted-therapy for the improvement of colon cancer.

« Previous Next »
[1]
Haggar F, Boushey R. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22(4): 191-7.
[http://dx.doi.org/10.1055/s-0029-1242458] [PMID: 21037809]
[2]
Cancer GAN. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487(7407): 330-7.
[http://dx.doi.org/10.1038/nature11252] [PMID: 22810696]
[3]
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5): 759-67.
[http://dx.doi.org/10.1016/0092-8674(90)90186-I] [PMID: 2188735]
[4]
Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009; 10(6): 353-8.
[http://dx.doi.org/10.1038/nrg2574] [PMID: 19434079]
[5]
Jácome AA, Eng C. Role of immune checkpoint inhibitors in the treatment of colorectal cancer: Focus on nivolumab. Expert Opin Biol Ther 2019; 19(12): 1247-63.
[http://dx.doi.org/10.1080/14712598.2019.1680636] [PMID: 31642347]
[6]
Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59(6): 366-78.
[http://dx.doi.org/10.3322/caac.20038] [PMID: 19897840]
[7]
Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol 2018; 11(1): 107.
[http://dx.doi.org/10.1186/s13045-018-0645-x] [PMID: 30139373]
[8]
Kanda M, Nomoto S, Okamura Y, et al. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. Int J Oncol 2009; 35(3): 477-83.
[PMID: 19639168]
[9]
Huang Y, de la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression ofMT1G andCRABP1 in papillary thyroid carcinoma. Int J Cancer 2003; 104(6): 735-44.
[http://dx.doi.org/10.1002/ijc.11006] [PMID: 12640681]
[10]
Hung KC, Huang TC, Cheng CH, et al. The expression profile and prognostic significance of metallothionein genes in colorectal cancer. Int J Mol Sci 2019; 20(16): 3849.
[http://dx.doi.org/10.3390/ijms20163849] [PMID: 31394742]
[11]
Arriaga JM, Bravo AI, Mordoh J, Bianchini M. Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells. Oncol Rep 2017; 37(5): 2633-51.
[http://dx.doi.org/10.3892/or.2017.5547] [PMID: 28393194]
[12]
Nguyen L, Papenhausen P, Shao H. The role of c-MYC in B-Cell lymphomas: Diagnostic and molecular aspects. Genes 2017; 8(4): 116.
[http://dx.doi.org/10.3390/genes8040116] [PMID: 28379189]
[13]
Sears RC. The life cycle of C-myc: From synthesis to degradation. Cell Cycle 2004; 3(9): 1131-5.
[http://dx.doi.org/10.4161/cc.3.9.1145] [PMID: 15467447]
[14]
Kanapathipillai M. Treating p53 mutant aggregation-associated cancer. Cancers 2018; 10(6): 154.
[http://dx.doi.org/10.3390/cancers10060154] [PMID: 29789497]
[15]
Liu J, Wen Y, Liu Z, et al. VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer. Mol Ther Nucleic Acids 2021; 23: 324-35.
[http://dx.doi.org/10.1016/j.omtn.2020.11.010] [PMID: 33425490]
[16]
Liang Z, Liu Z, Cheng C, et al. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma. Cell Death Dis 2019; 10(4): 305.
[http://dx.doi.org/10.1038/s41419-019-1457-9] [PMID: 30944308]
[17]
Wang Y, Wang G, Tan X, et al. MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53. Oncogenesis 2019; 8(12): 67.
[http://dx.doi.org/10.1038/s41389-019-0176-5] [PMID: 31732712]
[18]
Lu W, Zhang H, Niu Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer 2017; 16(1): 118.
[http://dx.doi.org/10.1186/s12943-017-0685-9] [PMID: 28697764]
[19]
Yu Y, Wu X, Liu S, et al. Piezo1 regulates migration and invasion of breast cancer cells via modulating cell mechanobiological properties. Acta Biochim Biophys Sin 2020; 53(1): 10-8.
[http://dx.doi.org/10.1093/abbs/gmaa112] [PMID: 33210711]
[20]
Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D’Orazi G. Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging 2016; 8(4): 603-19.
[http://dx.doi.org/10.18632/aging.100934] [PMID: 27019364]
[21]
West AK, Stallings R, Hildebrand CE, Chiu R, Karin M, Richards RI. Human metallothionein genes: Structure of the functional locus at 16q13. Genomics 1990; 8(3): 513-8.
[http://dx.doi.org/10.1016/0888-7543(90)90038-V] [PMID: 2286373]
[22]
Zeng J, Zhang N, Zhao G, et al. MT1G is silenced by DNA methylation and contributes to the pathogenesis of hepatocellular carcinoma. J Cancer 2018; 9(16): 2807-16.
[http://dx.doi.org/10.7150/jca.25680] [PMID: 30123349]
[23]
Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene 2008; 27(50): 6462-72.
[http://dx.doi.org/10.1038/onc.2008.312] [PMID: 18955973]
[24]
Shen C, Chen F, Wang H, et al. The pinx1 gene downregulates telomerase and inhibits proliferation of CD133+ cancer stem cells isolated from a nasopharyngeal carcinoma cell line by regulating trfs and mad1/c-myc/p53 Pathways. Cell Physiol Biochem 2018; 49(1): 282-94.
[http://dx.doi.org/10.1159/000492878] [PMID: 30138944]
[25]
Wawryk-Gawda E, Chylińska-Wrzos P, Lis-Sochocka M, et al. P53 protein in proliferation, repair and apoptosis of cells. Protoplasma 2014; 251(3): 525-33.
[http://dx.doi.org/10.1007/s00709-013-0548-1] [PMID: 24043441]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy